Quantcast

Latest blindness Stories

2014-05-22 16:26:40

A Randomized Double-Blind Human Clinical Trial Evaluating the Efficacy of Lenstatin in Inhibiting Cataract Formation and Progression After Pars Plana Vitrectomy WILMINGTON, N.C., May 22, 2014 /PRNewswire/ -- There are conflicting scientific reports on the effectiveness of nutritional antioxidants in preventing or slowing the growth of age related cataracts, despite extensive basic science research indicating that oxidative damage to the human lens is a common underlying etiologic...

2014-05-22 08:30:52

Eye physicians volunteer to provide exams and care at no out-of-pocket cost for seniors through EyeCare America SAN FRANCISCO, May 22, 2014 /PRNewswire/ -- The American Academy of Ophthalmology - the world's largest association of eye physicians and surgeons - is issuing seven tips to help older adults take care of their eyes as they age to ensure longer independence and wellbeing. The Academy is offering the advice as part of its efforts to support the National Eye Institute's...

2014-05-22 08:28:41

MOUNTAIN VIEW, Calif., May 22, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that data from a one-year, multi-center study demonstrates the safety and durability of its proprietary MicroPulse technology as a treatment for glaucoma. The educational symposium was led by Drs. Ike Ahmed, David Gossage, and Elias Reichel and was attended by more than 300 ophthalmologists during the American Society of Cataract and Refractive Surgeons (ASCRS) conference in April....

2014-05-20 12:32:41

Introduction Of Single-Use, Pre-Sterilized MSICS Kit Increases Large-Scale Approach Toward The Elimination Of Blindness Due To Cataracts NEW YORK, May 20, 2014 /PRNewswire-USNewswire/ -- HelpMeSee - a global campaign to eliminate cataract blindness - today announced its cataract elimination expansion campaign to begin throughout 23 countries in Western (Franco-phone) and Sub-Saharan Africa countries through a new partnership that introduces the use of single-use, pre-sterilized MSICS...

2014-05-16 08:26:47

NUREMBERG, Germany, May 16, 2014 /PRNewswire/ -- Prof Mark S. Humayun delivers the honorary lecture: With Argus(R) II, retinal prostheses are a reality, outlining best achieved vision in 30 implanted patients after 5 years Die Innovator's Lecture or Albrecht-von-Graefe Lecture is one of the highlights of the International Congress of German Ophthalmic Surgeons (DOC) and an invitation to attend is a great distinction for...

2014-05-14 23:10:54

Dr. Michael Tracy of Carlsbad Eye Care Comments on American Academy of Ophthalmology Study Promoting Early Treatment for Glaucoma San Diego, CA (PRWEB) May 14, 2014 A study released by the American Academy of Ophthalmology gave new information on the status of glaucoma in the United States, including how approximately half of those affected by the potentially blinding disease aren’t even aware that they have it. Asymptomatic in its early stages, glaucoma is estimated to affect 2.7...

2014-05-14 12:22:24

TEL-AVIV, Israel, May 14, 2014 /PRNewswire/ -- BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has been informed that a patent number 8,722,739 covering the proprietary formulation of Latanoprost, the medication contained in its controlled release insert for the...

2014-05-13 08:30:57

DIEPENBEEK, Belgium, May 13, 2014 /PRNewswire/ -- Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma. Based on Amakem's 'Localized Drug Action' platform, AMA0076 is a highly potent locally-acting Rho Kinase (ROCK) inhibitor that has been designed to reduce intraocular pressure (IOP) by acting...

2014-05-12 11:53:53

Lunenfeld-Tanenbaum Research Institute Bioengineering a safe treatment for retinopathy, the leading cause of vision loss in Canada A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto. The growth of malformed blood vessels that can burst is a leading cause of vision loss in North America. Retinopathy and retina degeneration are associated with...

2014-05-05 16:26:38

KAILUA-KONA, Hawaii, May 5, 2014 /PRNewswire/ -- The Hawaii Cataract and Laser Institute (HCLI) welcomes Dr. John M. Tsue of Kona to its team of specialized eye doctors. As the owner of his own practice, Eyecare of Kona, the Doctor of Optometry, born and raised in Hilo, has been providing services to the community for the past 35 years. He expands the capabilities of his practice with advanced technology from the Hawaii Cataract and Laser Institute. Joining HCLI brings the...


Latest blindness Reference Libraries

0_68c852d52eeb6d2057e521f7d4c6ddc6
2010-09-23 19:56:17

The Braille system is a method that is widely used by blind people to read and write. It was devised in 1821 by Louis Braille, a blind Frenchman. The Braille characters are made up of six dot positions arranged in a rectangle containing two columns of three dots each. Including a subset when dots are not raised, there are sixty-four possible subsets. The positions on the grid are number 1-3 from top to bottom, on the left, and 4-6 from top to bottom on the right. Horizontal Braille text is...

More Articles (1 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related